Presentations include long-term GATHER2 open-label extension data, real-world treatment patterns on safety, and biomarker insights on geographic atrophy disease progression TOKYO, Oct. 8, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas")...
Hence then, the article about astellas to present new data on izervay avacincaptad pegol intravitreal solution in geographic atrophy at aao 2025 annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting )
Also on site :
- Walmart on Dewey Avenue in Greece closed to the public Thursday afternoon
- Vinyl Collectors Will Love Amazon’s ‘Attractive’ Retro 9-Tier Record Player Stand
- Carlos Puyol, David Villa & more in attendance for Spain vs Austria 2026 FIFA World Cup clash